Global Transdermal Drug Delivery Systems Market

According to the latest report by IMARC Group, titled " Global?Transdermal Drug Delivery Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global transdermal drug delivery systems market exhibited moderate growth during 2015-2020. Transdermal drug delivery (TDD) systems include the utilization of non-invasive methods for drug administration. In this method, the drug is penetrated via the stratum corneum, which is then passed through the dermis and the epidermis layer of the skin. In comparison with the conventional oral intravascular and parenteral route mode of drug delivery, these methods do not damage the skin layers or other tissues while improving the efficacy of the dosage. As a result, they are extensively utilized in the treatment of acute and chronic diseases as well as in cosmetic procedures. 

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.?? 

Global Transdermal Drug Delivery Systems Market Trends:? 

The global market is primarily driven by the increasing preference for self-administered modes of drug delivery. Coupled with the rising demand for non-invasive treatment methods among the masses, this is providing a boost to the market growth. Also, the rising preference for maintaining an aesthetic appearance among individuals has led to escalating demand for cosmetic surgeries, which is favorably impacting the market growth. Along with this, the increasing geriatric population and the rising prevalence of acute illnesses among individuals are creating a positive outlook for the market on the global level. Moreover, various technological advancements in the market, including the introduction of dissolving microneedles and sonophoresis techniques, are creating a positive outlook for the market. Other factors, including increasing healthcare expenditure, continuous improvements in the healthcare infrastructure and extensive research and development (R&D) activities conducted by key players to introduce?innovative product variants with improved quality, are further contributing to the market growth. On account of the aforementioned factors,?the market is anticipated to grow at a CAGR of around 6% during 2021-2026.

Market Summary:

• On the basis of the technology, the market has been segmented into electroporation, radiofrequency, iontophoresis, microporation, thermal, mechanical arrays, ultrasound and others.
• Based on the application, the market has been categorized into central nervous system, pain management, cardiovascular, hormone and others.
• On the basis of the region, the market has been divided into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
• The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800